mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has been rising in incidence primarily related to HPV‐associated oropharyngeal cancers. Novel molecular therapeutics are evolving with the mTOR pathway as a new target. Previous studies have shown variable outcomes with relatively low toxicit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Laryngoscope Investig Otolaryngol
Autori principali: Patel, Jaimin, Nguyen, Shaun A., Ogretmen, Besim, Gutkind, Jorge S., Nathan, Cherie‐Ann, Day, Terry
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Head and Neck, and Tumor Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7178455/
https://ncbi.nlm.nih.gov/pubmed/32337356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lio2.370
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi